INFLAMMATORY BOWEL DISEASE

Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn’s disease patients: the Florence IBD study 1978–2001

G Masala¹, S Bagnoli², M Ceroti¹, C Saieva¹, G Trallori², I Zanna¹, G d’Albasio³, D Palli¹

¹ Molecular and Nutritional Epidemiology Unit, CSPO-Scientific Institute of Tuscany, Florence, Italy
² Department of Gastroenterology, AO Careggi, Florence, Italy
³ Department of Gastroenterology, AO Careggi, Florence, Italy, and Regional IBD Referral Centre, Florence, Italy

Correspondence to:
Correspondence to:
Dr D Palli
Molecular and Nutritional Epidemiology Unit, CSPO-Scientific Institute of Tuscany, Via di San Salvi 12, 50135 Florence, Italy; d.palli{at}cspo.it

Background and aims: Two divergent patterns of mortality for smoking related diseases in ulcerative colitis and Crohn’s disease patients were suggested in a previous population based study in Florence, Italy. Long term follow up (median 15 years) was completed to re-evaluate mortality in this Mediterranean cohort.

Patients and methods: Overall, 920 patients with inflammatory bowel disease were followed until December 2001 or death, with seven patients (0.8%) lost to follow up. A total of 14 040 person years were available for analysis; 118 deaths were observed (81/689 in ulcerative colitis and 37/231 in Crohn’s disease). Expected deaths were estimated using age, sex, and calendar specific national and local mortality rates; standardised mortality ratios (SMR) and 95% confidence interval (CI) were calculated.

Results: Among Crohn’s disease patients, mortality was strongly increased for gastrointestinal diseases (SMR 4.49 (95% CI 1.80–9.25)), all cancers (SMR 2.10 (95% CI 1.22–3.36)), and lung cancer (SMR 4.00 (95% CI 1.60–8.24)), leading to a significant 50% excess total mortality. Ulcerative colitis patients showed a significantly reduced total mortality because of lower cardiovascular (SMR 0.67 (95% CI 0.45–0.95)) and lung cancer (SMR 0.32 (95% CI 0.07–0.95)) mortality. No significant excess for colorectal cancer mortality was evident in this extended follow up.

Conclusions: These clearly divergent patterns of mortality correlate with documented differences in smoking habits between Crohn’s disease and ulcerative colitis patients. Family doctors and gastroenterologists should consider stopping cigarette smoking a specific priority for Crohn’s disease patients; the latter should be offered free participation in structured programmes for smoking cessation, with the aim of reducing smoking related excess mortality. Overall, no evidence of an increased mortality for large bowel cancer emerged in this series.

Abbreviations: CD, Crohn’s disease; IBD, inflammatory bowel disease; SMR, standardised mortality ratio; UC, ulcerative colitis

Keywords: Crohn’s disease; ulcerative colitis; inflammatory bowel disease; mortality; epidemiology

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Digest

Robin Spiller
Gut 2004 53: 1217. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Hoie, O, Schouten, L J, Wolters, F L, Solberg, I C, Riis, L, Mouzas, I A, Politi, P, Odes, S, Langholz, E, Vatn, M, Stockbrugger, R W, Moum, B, on behalf of the European Collaborative Study Grou, (2007). Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis. Gut 56: 497-503 [Abstract] [Full Text]  
• Jess, T, Loftus, E V Jr, Harmsen, W S, Zinsmeister, A R, Tremaine, W J, Melton, L J III, Munkholm, P, Sandborn, W J (2006). Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut 55: 1248-1254 [Abstract] [Full Text]  
• Loftus, E V Jr (2006). Crohn's disease: why the disparity in mortality?. Gut 55: 447-449 [Full Text]